Envestnet Asset Management Inc Argenx Se Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Argenx Se stock. As of the latest transaction made, Envestnet Asset Management Inc holds 67,891 shares of ARGX stock, worth $42.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

67,891

Previous 62,999 7.77%

Holding current value

$42.4 Million

Previous $27.1 Million 35.91%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$434.22 - $551.9 $2.12 Million - $2.7 Million	4,892 Added 7.77%	67,891 $36.8 Million
Q2 2024 Aug 08, 2024	BUY	$356.01 - $451.55 $2.72 Million - $3.45 Million	7,645 Added 13.81%	62,999 $27.1 Million
Q1 2024 May 13, 2024	BUY	$356.95 - $413.29 $2.66 Million - $3.08 Million	7,454 Added 15.56%	55,354 $21.8 Million
Q4 2023 Feb 13, 2024	BUY	$338.91 - $506.01 $1.36 Million - $2.03 Million	4,013 Added 9.14%	47,900 $18.2 Million
Q3 2023 Nov 13, 2023	BUY	$369.35 - $548.43 $9.58 Million - $14.2 Million	25,940 Added 144.54%	43,887 $21.6 Million
Q2 2023 Aug 04, 2023	BUY	$360.14 - $422.58 $887,745 - $1.04 Million	2,465 Added 15.92%	17,947 $6.99 Million
Q1 2023 May 11, 2023	BUY	$334.23 - $403.65 $98,263 - $118,673	294 Added 1.94%	15,482 $5.77 Million
Q4 2022 Feb 07, 2023	SELL	$342.17 - $402.31 $5,132 - $6,034	-15 Reduced 0.1%	15,188 $5.75 Million
Q3 2022 Nov 10, 2022	BUY	$343.2 - $395.75 $580,694 - $669,609	1,692 Added 12.52%	15,203 $5.37 Million
Q2 2022 Aug 03, 2022	BUY	$269.58 - $378.88 $134,520 - $189,061	499 Added 3.83%	13,511 $5.12 Million
Q1 2022 May 04, 2022	BUY	$254.45 - $351.06 $1.35 Million - $1.86 Million	5,294 Added 68.59%	13,012 $4.1 Million
Q4 2021 Feb 04, 2022	BUY	$272.01 - $353.03 $347,900 - $451,525	1,279 Added 19.86%	7,718 $2.7 Million
Q3 2021 Oct 07, 2021	BUY	$295.0 - $350.58 $71,390 - $84,840	242 Added 3.91%	6,439 $1.94 Million
Q2 2021 Aug 04, 2021	SELL	$257.11 - $319.92 $1.35 Million - $1.68 Million	-5,255 Reduced 45.89%	6,197 $1.87 Million
Q1 2021 May 04, 2021	BUY	$268.3 - $380.31 $834,413 - $1.18 Million	3,110 Added 37.28%	11,452 $3.15 Million
Q4 2020 Feb 02, 2021	BUY	$248.13 - $308.36 $186,841 - $232,195	753 Added 9.92%	8,342 $2.45 Million
Q3 2020 Oct 09, 2020	SELL	$215.51 - $272.51 $75,428 - $95,378	-350 Reduced 4.41%	7,589 $1.99 Million
Q2 2020 Jul 08, 2020	SELL	$127.44 - $232.72 $382 - $698	-3 Reduced 0.04%	7,939 $1.79 Million
Q1 2020 Apr 23, 2020	BUY	$108.83 - $165.23 $80,751 - $122,600	742 Added 10.31%	7,942 $1.05 Million
Q4 2019 Feb 11, 2020	BUY	$106.59 - $164.21 $299,091 - $460,773	2,806 Added 63.86%	7,200 $1.16 Million
Q3 2019 Oct 17, 2019	SELL	$113.31 - $150.51 $29,233 - $38,831	-258 Reduced 5.55%	4,394 $501,000
Q2 2019 Aug 02, 2019	SELL	$115.0 - $141.58 $18,515 - $22,794	-161 Reduced 3.35%	4,652 $659,000
Q1 2019 May 10, 2019	SELL	$98.85 - $134.59 $21,549 - $29,340	-218 Reduced 4.33%	4,813 $601,000
Q4 2018 Feb 13, 2019	BUY	$63.81 - $109.82 $321,028 - $552,504	5,031 New	5,031 $483,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.5B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Argenx Se Transaction History